dermatology case report

Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine
Eruptive squamous cell carcinoma
by NEXT STEPS IN DERM TEAM on
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …

Continue reading "Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine"

Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea
rosacea
by NEXT STEPS IN DERM TEAM on
Rosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors and reducing inflammation with topical and oral therapies. Traditional therapies primarily focus on the papulopustular or background erythematotelangiectatic component of rosacea, leaving symptoms of flush …

Continue reading "Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea"

Severe Ulcerative Perniosis Treated With Botulinum Toxin
Botulinum Toxin
by NEXT STEPS IN DERM TEAM on
Perniosis (also known as pernio or chilblains), is a condition characterized by the development of pruritic, painful erythrocyanotic skin lesions induced by exposure to cold temperatures.² When perniosis occurs in conjunction with clinical or laboratory features of systemic lupus erythematosus, the condition is further classified as chilblain lupus erythematosus (CHLE). CHLE is a rare condition w …

Continue reading "Severe Ulcerative Perniosis Treated With Botulinum Toxin"

Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar Pustulosis
by NEXT STEPS IN DERM TEAM on
Palmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …

Continue reading "Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis"

Topical Cannabinoids for the Management of Psoriasis Vulgaris
Cannabinoids for Psoriasis
by NEXT STEPS IN DERM TEAM on
Authors Adam J. Friedman MD, Kimia Momeni BS, and Mikhail Kogan MD present a case of a young man with psoriasis managed with topical cannabinoids. Introduction The interest in use of medical cannabis for chronic dermatologic conditions such as psoriasis, eczema, and acne has been growing mostly owing to rapidly emerging decriminalization across the country and impressive commercially driven popu …

Continue reading "Topical Cannabinoids for the Management of Psoriasis Vulgaris"